Medicinal Plants with Potential Inhibitory Bioactive Compounds against Coronaviruses

Author:

Adeleye Olutayo Ademola1,Bamiro Oluyemisi Adebowale1,Bakre Lateef Gbenga1ORCID,Odeleye Florence Olubola2ORCID,Adebowale Modupe Nofisat3,Okunye Olufemi Lionel2,Sodeinde Mariam Adeola3,Adebona Adannaya Charity4,Menaa Farid5ORCID

Affiliation:

1. Department of Pharmaceutics and Pharmaceutical Technology, Olabisi Onabanjo University, Ago -Iwoye, Ogun State, Nigeria.

2. Department of Pharmaceutical Microbiology,Olabisi Onabanjo University, Ago Iwoye, Ogun State, Nigeria.

3. Department of Pharmacognosy Olabisi Onabanjo University, Ago Iwoye, Ogun State, Nigeria.

4. Department of Pharmaceutics and Pharmaceutical Technology, University of Lagos, Lagos State.

5. Department of Translational Nanomedicine and Advanced Technologies California Innovations Corporation, San Diego, La Jolla, California, USA.

Abstract

Medicinal plant is a major source of drug discovery for disease management. Over 85% of the population in Asia and in the Middle East use herbal medicine for disease management such as SARS caused by coronavirus. Infection from coronavirus is initiated by entry of the virus into a susceptible host cell. The two human coronaviruses of public health importance two decades ago were SARS-CoV and MERS-CoV and now SARS-CoV 2. These three viruses belong to the same class of beta coronavirus and are somewhat similar in genome sequencing, life cycle, mode of entry into a host, mode of transmission and clinical manifestations. This review identified twenty medicinal plants with potential inhibitory bioactive compounds from natural sources that are active against coronaviruses that could be developed into various drug delivery systems. It also highlighted several evidences to show that medicinal plant used in the treatment of SARS-CoV may offer some sort of relief from the burden of COVID 19 pandemic. Since there is no specific treatment for COVID 19 yet, the search for medicinal plants with inhibitory bioactive compounds against coronavirus could be the long awaited breakthrough scientists have been searching to change the narratives of Covid-19 pandemic.

Publisher

Maad Rayan Publishing Company

Subject

General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3